StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.46−0.02 (-1.35%)

Close on Nov 18, 2026Market cap $519.11MP/E –Yield –

Evotec pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Evotec's pe ratio was 12.9× on Feb 28, 2023, against 653.5× a year earlier. Over the last 3 years it ranged from 11.6× to 962.8×, with a median of 91.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 202312.9×+1.3
2022Dec 30, 202211.6×−847.8
2021Jul 30, 2021859.4×+739.4
2020Dec 31, 2020120.0×–

More Evotec figures

See a number that looks wrong?